ArticleDiabetology & metabolic syndrome2025
Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.
Ming-Hsun Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it